Showing results (51-60 of 173) with videos related to
Sort By:
Pageof 18
The International Journal of Neuropsychopharmacology|February 26, 2014
Metabolomic profiling of schizophrenia patients at risk for metabolic syndromeR Madelaine Paredes, Marlon Quinones, Ketan Marballi, et al.Molecular Neuropsychiatry|April 26, 2019
X-Aptamer Technology Identifies C4A and ApoB in Blood as Potential Markers for SchizophreniaConsuelo Walss-Bass, Ganesh L R Lokesh, Elena Dyukova, et al.Translational Psychiatry|April 29, 2021
White matter deficits in cocaine use disorder: convergent evidence from in vivo diffusion tensor imaging and ex vivo proteomic analysisLucca Pizzato Tondo, Thiago Wendt Viola, Gabriel R Fries, et al.Plos One|November 9, 2018
Anhedonia in cocaine use disorder is associated with inflammatory gene expressionGabriel Rodrigo Fries, Sarwar Khan, Sydney Stamatovich, et al.Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Types of Traumatic Experiences in Drug Overdose-Related Deaths: An Exploratory Latent Class AnalysisJudy H Hong, Constanza de Dios, Jessica C Badawi, et al.Methods in Molecular Biology (Clifton, N.J.)|February 14, 2018
Exosomal MicroRNAs as Potential Biomarkers in Neuropsychiatric DisordersGabriel R Fries, Joao QuevedoInternational Journal of Molecular Sciences|January 16, 2020
Molecular Psychiatry: Trends and Study ExamplesTheo Rein, Gabriel R FriesJournal of Clinical Psychopharmacology|November 5, 2016
Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic SchizophreniaQiongzhen Li, Dachuan Chen, Tiebang Liu, et al.Molecular Psychiatry|August 13, 2021
Angiogenic gene networks are dysregulated in opioid use disorder: evidence from multi-omics and imaging of postmortem human brainEmily F Mendez, Haichao Wei, Ruifeng Hu, et al.Journal of Molecular Medicine (Berlin, Germany)|July 14, 2010
In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulationKetan Marballi, Marlon P Quinones, Fabio Jimenez, et al.Pageof 18